HIGHLIGHTS
- who: Epimedin C and colleagues from the Wuhan Hospital of Traditional Chinese and Western Medicine, Wuhan, Hubei, China College of Life Science Gannan Normal University, Jiangxi, China have published the research work: AGING, in the Journal: (JOURNAL)
- what: The authors used DXMS-induced OBs and a rodent model to evaluate the role of Epimedin C in DXMSinduced OP and identified the related target genes and proteins. This model provides a cellular platform for verifying the drug properties of Epimedin C. Finally, the pathway that Epimedin C influenced in OB cells were found and confirmed, phenotype . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.